XNAS: GRCE
Grace Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for t...
Read More
4.20
0.14
(3.45%)
368.6K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Grace Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..